Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2002 / Cilt: 36 - Sayı: 2

Drug induced psoriasis

İlaçla uyarılan psoriyazis

Pages
105–109
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The importance of not using provoking drugs in psoriasis patients has been emphasized.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and design: Various provoking factors have been affecting the clinical course of psoriasis and drugs have an important role among these factors.
📊
Key Findings & Data:Then, drugs that had been taken by 156 psoriasis patients who were hospitalized in our clinic were determined.
💡
Conclusion & Impact:Conclusion: The importance of not using provoking drugs in psoriasis patients has been emphasized.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and design: Various provoking factors have been affecting the clinical course of psoriasis and drugs have an important role among these factors. Materials and methods: A list of drugs were arranged which have been known to provoke psoriasis. Then, drugs that had been taken by 156 psoriasis patients who were hospitalized in our clinic were determined. Results: Among those patients, 47.43% (74 patients) used drugs that have been indicated as provoking psori-asis, 26.28% (41 patients) used drugs that have not been indicated as provoking psoriasis and 26.28% (41 patients) did not take any drug. Conclusion: The importance of not using provoking drugs in psoriasis patients has been emphasized.

Özet

Psoriyaziste klinik bulguların gelişiminde çeşitli etmenlerin rolleri bulunmaktadır. Bu etmenlerin arasında ilaçların da önemli bir yeri vardır. Bu çalışmada, kaynaklarda konu ile ilgili çalışmalar incelenerek psoriyazisi uyardığı bildirilen ilaçların taramasının yapılması yanında, kliniğimizde yatarak sağaltım gören 156 psoriyazis olgusunun klinik aktivasyon öncesinde kullandıkları ve sağaltım sırasında aldıkları ilaçların da dökümü yapılmıştır. Bu olgulardan 74'ünde (%47.43) psoriyazisi uyardığı bildirilen ilaçların, 41'inde (%26.28) psoriyazisi uyardığı bildirilenlerin dışında ilaçların kullanıldığı, 41'inde (%26.28) ise hiçbir ilacın kullanılmadığı belirlenmiştir. Kaynak bilgileri ışığında psoriyazisi uyaran ilaçların etkileri tartışılmış ve psoriyazis olgularında dermatozu uyardığı bildirilen ilaç kullanımından kaçınılmasının önemi vurgulanmıştır.

🔖

Cite This Article

FETİL, E., İLKNUR, T., ÖZKAN, Ş., GÜNEŞ, A. T., ÖZTÜRK, B., ÜNSAY, E., AĞDANLI, D., BİRGİN, B. (2022). Drug induced psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 36 - Sayı: 2, 105–109. https://ajindex.com/articles/622291

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (21)

  1. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK: Dermatology. 3. baskı. Berlin,-Springer Verlag, 1991;417-437
  2. Christophers E, Sterry W: Psoriasis. Dermatology in General Medicine. Ed. Fitzpatrick TB, Eisen A, Wolff K, Freedberg IM, Austen KF
  3. Baskı. New-York, McGraw-Hill, 1993;489-514
  4. Tsankov N, Kazandjieva J, Drenovska K: Drugs in exacerbation and provocation of psoriasis. Clin Dermatol 1998;16:333-351
  5. Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM: Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007-1022
  6. Sasaki T, Saito S, Aihara M, Ohsawa J, Ikezewa Z: Exacerbation of psoriasis during lithium treatment. J Dermatol 1989;16:59-63
  7. Pande AC, Max P, Donnelly RF: Lithium associated with psoriasis. J Clin Psychiatry 1986;47:330
  8. Lin XR, Huang T, Yang CM: Histological changes induced by applicati¬on of lithium carbonate to mouse ear skin. Arc Dermatol Res 1990;282:280-281
  9. Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH: Lithium therapy associated with hidradenitis suppurativa: case report and a review of dermatologic side effects of lithium. J Am Acad Dermatol 1995;32:382-386
  10. Gold MH, Holy AK, Roenigk HH: Beta-blocking drugs and psoriasis. J Am Acad Dermatol 1988;19:837-841
  11. Hu C, Miller C, Peppercorn R, Farber EM: Generalized pustular psori¬asis provoked by propranolol. Arch Dermatol 1985;121:1326-1327
  12. Halevy S, Livni E. Psoriasis and psoriasiform eruptions associated with propranolol-the role of an immunological mechanism. Arch Dermatol Res1991;283:472-473
  13. Arntzen N, Kavli G, Volden G: Psoriasis provoked by b-blocking agents. Acta Derm Venerol (Stockh) 1984;65:346-348
  14. Macfarlane DG, Settas L: Acute psoriatic artropathy precipitated by oxprenolol. Ann Rheum Dis 1984;43:102-104
  15. Gawkrodger DJ, Beveridge GW: Psoriasiform reaction to atenolol. Clin Exp Dermatol 1984;9:92-94
  16. Wakefield PE: Atenolol induced pustular psoriasis. Arch Dermatol 1990;126:968-969
  17. White WB, Schulman P, McCabe El: Psoriasiform cutaneous eruptions induced by cetamolol hydrochloride. Arch Dermatol 1986;122:857-858
  18. Heng MCY, Heng MK: Beta-adrenoceptor antagonist-induced psoriasiform eruption. Int J Dermatol 1988;27:619-627
  19. Litt JZ, Pawlak WA: Drug eruption reference manual. New York, Parthenon, 1997
  20. Puig L, Goni FJ, Roque AM, Bordas FD, Moragas JM: Psoriasis induced by ophthalmic timolol preparations. Am J Ophthalmol 1989;108:455-456
  21. Powles AV, Griffiths CEM, Seifert MH, Fr